Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. - Wikidata - wikimedia - TriplyDB

Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.

Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.

http://www.wikidata.org/entity/Q35551783

about

Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration.Abnormal cardiac strain in children and young adults with HIV acquired in early life.Impact of HIV infection on diastolic function and left ventricular mass.Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life.Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.Isothiocyanates ameliorate the symptom of heart dysfunction and mortality in a murine AIDS model by inhibiting apoptosis in the left ventricle Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1 Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.Declining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus-Infected Individuals Treated With Highly Active Antiretroviral Therapy Relationships among HIV infection, metabolic risk factors, and left ventricular structure and function Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial Left ventricular dysfunction in human immunodeficiency virus infection.Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.Cardiovascular complications in children with HIV infection.HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.Preventing pediatric cardiomyopathy: a 2015 outlook.Sex-specific lean body mass predictive equations are accurate in the obese paediatric population.Increased left ventricular posterior wall end-diastolic thickness in adolescents with delayed diagnosis of vertically acquired HIV infection.High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.Cardiovascular profile and events of US adults 20-49 years with HIV: results from the NHANES 1999-2008.N-acetylcysteine reverses cardiac myocyte dysfunction in HIV-Tat proteinopathy.Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents.Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.

P2860

Q30397743-644447AA-BE22-44D8-953D-8170661C6AFB Q30452923-381A2B92-F0FE-4501-8A26-3FB581140E4A Q33721647-6C30C225-4EA9-4DA8-AD0B-30114B43D384 Q34269964-904CF424-BFA7-48F8-B7E4-F948D86B6BD0 Q34745570-C49982E1-E53B-43CA-9304-81ED94AE0899 Q35103300-0B307435-89CC-4C98-AFAB-B1B41DAA935C Q35296597-ADD3FF41-1618-4703-873C-3B4ECF2C78E0 Q35626381-5F9C3C1E-F5D0-41FF-A04C-9B23AF79BD49 Q35925270-601FAC2B-7CDD-4479-8526-ED649296871E Q36194188-DE4191BB-27E5-4C87-AB8A-BCB738C6449F Q36208623-5611BA56-D5B2-415B-A9A2-2D1A79C89A63 Q36441790-B2392E48-F850-43D6-9E9B-5174B6DBD56C Q36555275-84329C9E-6A0D-4A54-A3E0-4BFFEFB4B78D Q36812073-37C2A143-558B-49D6-A30F-D13244BBA977 Q36941650-01B8976E-C6B9-455B-B59F-FDCB77F8CAC7 Q36942884-EA7CC3E3-32D7-4900-A474-80C38BC662D9 Q36988601-83858430-A402-47F4-9182-20E1881BED02 Q37025613-3D732019-C701-46F9-93E1-10E8CE2F699C Q37129069-464C120D-A6E7-4EC6-9A5D-3C957D7BD439 Q37153504-72667365-2461-4C40-A171-4DF8D80D9171 Q37520430-0FF90B44-62ED-45BA-8E2C-FA9C8E57090B Q37885231-AD2F678D-522D-4AB7-A4CB-23EF701FF7B5 Q38021848-D55EA9FA-5D4B-41B4-82B4-C5484EE970A1 Q38662111-EFC41739-671A-45A5-9BB4-EC76A549462C Q38972839-F55584B9-40B7-4CD4-BC2D-DA48B3F153FD Q42716811-A28F3589-8070-4FAC-98D4-23705398DEE9 Q44307756-79D2E021-B0FE-4ABD-9BBA-EFD0B0B0935D Q44902091-41615751-C473-40CE-8313-70830CF5BBA9 Q44975297-220594E9-4B27-4B07-AF80-039AF370186D Q47279256-4C9BFE38-0BB2-4CCC-B361-9F6C5FFD40A2 Q47629689-19A3D884-60E6-4CE1-A297-FA174B71E1A2

P2860

Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.

http://www.wikidata.org/entity/Q35551783

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Mild dilated cardiomyopathy an ...... ve P2C2 HIV Multicenter Study.

@ast

Mild dilated cardiomyopathy an ...... ve P2C2 HIV Multicenter Study.

@en

type

label

Mild dilated cardiomyopathy an ...... ve P2C2 HIV Multicenter Study.

@ast

Mild dilated cardiomyopathy an ...... ve P2C2 HIV Multicenter Study.

@en

prefLabel

Mild dilated cardiomyopathy an ...... ve P2C2 HIV Multicenter Study.

@ast

Mild dilated cardiomyopathy an ...... ve P2C2 HIV Multicenter Study.

@en

P1433

Q35551783-2CD83B28-8267-44D8-8BC5-A75F46FFDAC8

P1476

Q35551783-C339AAFA-8A72-4FEC-AE59-19FF5FFBC063

P2093

Q35551783-053ACA20-CFDF-453E-AC7C-E392CEE6CBC4

Q35551783-08AE0126-CA40-44F9-B4FF-CD4A53B80CDD

Q35551783-12EE9340-F0BE-40D0-A310-43C7A5110EC2

Q35551783-2E5465E5-8570-4688-AE50-F159D1975E70

Q35551783-4514687A-B2B4-41A8-903A-FED9CD15DEB8

Q35551783-5030EE37-9700-4DE0-9FD8-B39824ADFC1B

Q35551783-5086DC70-3135-4BDC-A6AA-6EED420FD83B

Q35551783-7748AB9B-E549-4686-AD0A-05CC73EDC7F7

Q35551783-7A80BC23-30BA-4EB2-8872-6BE4B73520C5

Q35551783-7C1E238B-BB4A-4385-91A5-9507193BA15E

P2860

Q35551783-12128984-C0AB-47DA-B1D4-A3837922A50D

Q35551783-24A59891-0282-496C-8F42-54DEE06BE4EC

Q35551783-37117BF3-B9FE-4924-A287-4F8280007376

Q35551783-4FB12B91-BFCE-4320-A99A-D386314F120A

Q35551783-6124FC05-E276-4067-914D-E17E2DA22057

Q35551783-A0AF44CA-FD36-4328-8150-83785C5CA962

Q35551783-AE40A621-99AA-4A76-BA3C-8D9ACEE5746A

Q35551783-B4FF5818-1F43-44AF-A6BD-7B8DDCDA8B03

Q35551783-D53DF7DC-359E-4A08-AA3D-9FF6D756DBB5

Q35551783-F0A417B6-C219-4106-BA73-345E5F19232C

P304

Q35551783-90B8AB44-F92B-4E75-9E79-21D80737E2A8

P31

Q35551783-9F140AE8-74F8-494B-B081-9CDAC544EBC5

P356

Q35551783-C3A61649-B19F-47E8-9550-A55A87F62904

P407

Q35551783-49A6C679-A9B4-4E58-A2A5-E39A62C770B7

P433

Q35551783-A5D5E346-3D6A-444F-98E8-06522AC8BB2C

P478

Q35551783-35723D07-DBD9-4F30-A7E5-5EE74674D01F

P50

Q35551783-49F8BE0F-C2CB-4B01-86DB-4A54AB58A774

P577

Q35551783-05FD6C6B-D3D3-4B3A-B970-1196755C6E2B

P5875

Q35551783-CD91FC95-CDC8-4F19-8C01-5F497E078276

P698

Q35551783-757C3EE2-41D4-49FA-9E0B-F11FDE3F5C02

P921

Q35551783-5243D45B-1AF3-4759-A4A9-C424E195C9B2

P932

Q35551783-7F3862DD-E247-4AA0-B21F-90CE51A1C9FD

P356

J.AHJ.2005.06.012

P1433

American Heart Journal

P1476

Mild dilated cardiomyopathy an ...... ive P2C2 HIV Multicenter Study

@en

P2093

Douglas S Moodie

http://www.w3.org/2001/XMLSchema#string

E John Orav

http://www.w3.org/2001/XMLSchema#string

George Sopko

http://www.w3.org/2001/XMLSchema#string

J Timothy Bricker

http://www.w3.org/2001/XMLSchema#string

Pediatric Pulmonary and Cardio ...... fection (P2C2 HIV) Study Group

http://www.w3.org/2001/XMLSchema#string

Samuel Kaplan

http://www.w3.org/2001/XMLSchema#string

Stacy D Fisher

http://www.w3.org/2001/XMLSchema#string

Steven D Colan

http://www.w3.org/2001/XMLSchema#string

Steven E Lipshultz

http://www.w3.org/2001/XMLSchema#string

Thomas J Starc

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study

Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study.

Pediatric HIV-1 infection: advances and remaining challenges.

Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study

Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study.

Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study

Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute.

Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project.

P304

439-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AHJ.2005.06.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7595071

http://www.w3.org/2001/XMLSchema#string

P698

16169321

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4414122

http://www.w3.org/2001/XMLSchema#string